352 related articles for article (PubMed ID: 26060376)
1. Role of Advanced Glycation End Products and Its Receptors in the Pathogenesis of Cigarette Smoke-Induced Cardiovascular Disease.
Prasad K; Dhar I; Caspar-Bell G
Int J Angiol; 2015 Jun; 24(2):75-80. PubMed ID: 26060376
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
Prasad K; Tiwari S
Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
[TBL] [Abstract][Full Text] [Related]
3. Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals.
Scavello F; Tedesco CC; Castiglione S; Maciag A; Sangalli E; Veglia F; Spinetti G; Puca AA; Raucci A
Biomark Med; 2021 Aug; 15(11):785-796. PubMed ID: 34236256
[TBL] [Abstract][Full Text] [Related]
4. Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality.
Prasad K
Int J Angiol; 2014 Mar; 23(1):11-6. PubMed ID: 24627612
[TBL] [Abstract][Full Text] [Related]
5. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease.
Prasad K; Dhar I; Zhou Q; Elmoselhi H; Shoker M; Shoker A
Mol Cell Biochem; 2016 Dec; 423(1-2):105-114. PubMed ID: 27714575
[TBL] [Abstract][Full Text] [Related]
6. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
[TBL] [Abstract][Full Text] [Related]
8. Advanced Glycation End Products and its Soluble Receptors in the Pathogenesis of Thoracic Aortic Aneurysm.
Prasad K; Sarkar A; Zafar MA; Shoker A; Moselhi HE; Tranquilli M; Ziganshin BA; Elefteriades JA
Aorta (Stamford); 2016 Feb; 4(1):1-10. PubMed ID: 27766267
[TBL] [Abstract][Full Text] [Related]
9. AGE-RAGE Stress and Coronary Artery Disease.
Prasad K
Int J Angiol; 2021 Mar; 30(1):4-14. PubMed ID: 34025091
[TBL] [Abstract][Full Text] [Related]
10. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
[TBL] [Abstract][Full Text] [Related]
11. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
[TBL] [Abstract][Full Text] [Related]
12. Do Advanced Glycation End Products and Its Receptor Play a Role in Pathophysiology of Hypertension?
Prasad K; Mishra M
Int J Angiol; 2017 Mar; 26(1):1-11. PubMed ID: 28255209
[TBL] [Abstract][Full Text] [Related]
13. Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients.
Katakami N; Matsuhisa M; Kaneto H; Matsuoka TA; Sakamoto K; Yasuda T; Yamasaki Y
Diab Vasc Dis Res; 2008 Sep; 5(3):190-7. PubMed ID: 18777492
[TBL] [Abstract][Full Text] [Related]
14. AGE-RAGE Axis in the Pathophysiology of Chronic Lower Limb Ischemia and a Novel Strategy for Its Treatment.
Prasad K; Bhanumathy KK
Int J Angiol; 2020 Sep; 29(3):156-167. PubMed ID: 33041612
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism.
Caspar-Bell G; Dhar I; Prasad K
Mol Cell Biochem; 2016 Mar; 414(1-2):171-8. PubMed ID: 26895319
[TBL] [Abstract][Full Text] [Related]
16. Atherosclerosis and the Hypercholesterolemic AGE-RAGE Axis.
McNair E; Qureshi M; Prasad K; Pearce C
Int J Angiol; 2016 Jun; 25(2):110-6. PubMed ID: 27231427
[TBL] [Abstract][Full Text] [Related]
17. Ratio of serum levels of AGEs to soluble form of RAGE is a predictor of endothelial function.
Kajikawa M; Nakashima A; Fujimura N; Maruhashi T; Iwamoto Y; Iwamoto A; Matsumoto T; Oda N; Hidaka T; Kihara Y; Chayama K; Goto C; Aibara Y; Noma K; Takeuchi M; Matsui T; Yamagishi S; Higashi Y
Diabetes Care; 2015 Jan; 38(1):119-25. PubMed ID: 25336748
[TBL] [Abstract][Full Text] [Related]
18. Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging.
Scavello F; Zeni F; Tedesco CC; Mensà E; Veglia F; Procopio AD; Bonfigli AR; Olivieri F; Raucci A
Aging (Albany NY); 2019 Mar; 11(6):1648-1663. PubMed ID: 30903794
[TBL] [Abstract][Full Text] [Related]
19. AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment.
Prasad K
Int J Angiol; 2020 Jun; 29(2):72-80. PubMed ID: 32476808
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study.
Sabbatinelli J; Castiglione S; Macrì F; Giuliani A; Ramini D; Vinci MC; Tortato E; Bonfigli AR; Olivieri F; Raucci A
Cardiovasc Diabetol; 2022 Jun; 21(1):95. PubMed ID: 35668468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]